HBIO Latest Quarter's Earnings
Announce Date 03/12/2025
EPS Normalized Actual $0.06 (Beat by $0.01)
EPS GAAP Actual $0.06 (Beat by $0.01)
Revenue Actual $0.024556B
Revenue Surprise Beat by $24.556M
Upcoming Quarter's Earnings
Announce Date 06/30/2025 (Pre-Market)
EPS Normalized Estimate $0.09
EPS GAAP Estimate $0.09
Revenue Estimate $0.0321B
Annual EPS Estimate
Fiscal Period Ending EPS Estimate Forward PE Low High # of Analysts
Dec 2026 0.17 1.79 0.16941 0.17097 1
Dec 2025 0.17 1.79 0.17 0.17 1
Quarterly EPS History
Period EPS Beat / Miss Revenue YoY Beat / Miss
FQ4 2024 (Dec 2024) 0.0004 -0.046267 0.024556B -14.65% -3.71M
FQ3 2024 (Sep 2024) -0.11 -0.163333 0.02197B -15.44% -6.6M
FQ2 2024 (Jun 2024) -0.0673 -1.40565 0.023097B -24.51% -21.29M
FQ1 2024 (Mar 2024) -0.11 -0.17 0.024512B -22.29% -15.52M
FQ4 2023 (Dec 2023) -0.0429 -0.0429 0.028153B -0.97% 28.15M
FQ3 2023 (Sep 2023) -0.029 -0.029 0.025363B -6.15% 25.36M
FQ2 2023 (Jun 2023) -0.0231 -0.0231 0.028759B -1.56% 28.76M
FQ1 2023 (Mar 2023) 0.0148 0.0148 0.029975B 100% 29.98M
Quarterly Estimates Summary

FQ4 Announce Date

06/30/2025 (Pre-Market)

Consensus EPS Estimates

0.09

Consensus Revenue Estimates

0.0321B

Consensus EPS Estimates
Fiscal Period Ending EPS Estimate YoY Growth(%) Low High # of Analysts
FQ3 2026 (Sep 2026) -0.01 -- -0.01019797 -0.00980203 1
FQ2 2026 (Jun 2026) 0.02 -- 0.01960406 0.02039594 1
FQ1 2026 (Mar 2026) -0.04 -- -0.04079188 -0.03920812 1
FQ4 2025 (Oct 2025) 0.06 99.33 0.05854601 0.06107067 1
FQ3 2025 (Jul 2025) 0.09 222.22 0.08781901 0.091606 1
FQ2 2025 (Jun 2025) 0.09 174.78 0.08725032 0.09217417 1
Consensus Revenue Estimates
Fiscal Period Ending Revenue Estimate YoY Growth(%) Low High # of Analysts
FQ3 2026 (Sep 2026) 0.02B -- 0.02B 0.02B 1
FQ2 2026 (Jun 2026) 0.02B -- 0.02B 0.02B 1
FQ1 2026 (Mar 2026) 0.02B -- 0.02B 0.02B 1
FQ4 2025 (Oct 2025) 0.03B 19.49 0.03B 0.03B 0
FQ3 2025 (Jul 2025) 0.03B 31.56 0.03B 0.03B 0
FQ2 2025 (Jun 2025) 0.03B 28.05 0.03B 0.03B 0
Quarterly Estimates Revisions

EPS # of Up Revisions

4

EPS # of Down Revisions

4

Revenue # of Up Revisions

6

Revenue # of Down Revisions

3

Consensus EPS Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Consensus Revenue Revision Trend
Fiscal Period Ending EPS Estimate YoY Growth Low High # of Analysts
FQ4 2021 (Dec 2021) 0.41 -12.52% 0.39 0.48 20
FQ1 2022 (Mar 2022) 0.59 6.89% 0.55 0.62 15
FQ2 2022 (Jun 2022) 0.70 2.62% 0.61 0.74 15
FQ3 2022 (Sep 2022) 0.68 4.62% 0.65 0.70 15
Earnings Surprise Summary

EPS # of Beats

1

EPS # of Misses

7

EPS # of in-lines

0

Revenue # of Beats

4

Revenue # of Misses

4

Revenue # of in-lines

0

Earnings Surprise (EPS) - Actual vs Consensus
Earnings Date EPS Estimate EPS Actual Surprise Surprise %
FQ4 2024 (Dec 2024) 0.046667 0.0004 -0.046267 -11566.75%
FQ3 2024 (Sep 2024) 0.053333 -0.11 -0.163333 148.48%
FQ2 2024 (Jun 2024) 1.33835 -0.0673 -1.40565 2088.63%
FQ1 2024 (Mar 2024) 0.06 -0.11 -0.17 154.55%
FQ4 2023 (Dec 2023) -0.0429 -0.0429 100%
FQ3 2023 (Sep 2023) -0.029 -0.029 100%
FQ2 2023 (Jun 2023) -0.0231 -0.0231 100%
FQ1 2023 (Mar 2023) 0.0148 0.0148 100%
Revenue Surprise - Actual vs Consensus
Earnings Date Revenue Estimate Revenue Actual Surprise Surprise %
FQ4 2024 (Dec 2024) $0.03B $0.02B $-3.71M -15.11%
FQ3 2024 (Sep 2024) $0.03B $0.02B $-6.6M -30.03%
FQ2 2024 (Jun 2024) $0.04B $0.02B $-21.29M -92.17%
FQ1 2024 (Mar 2024) $0.04B $0.02B $-15.52M -63.32%
FQ4 2023 (Dec 2023) $0B $0.03B $28.15M 100%
FQ3 2023 (Sep 2023) $0B $0.03B $25.36M 100%
FQ2 2023 (Jun 2023) $0B $0.03B $28.76M 100%
FQ1 2023 (Mar 2023) $0B $0.03B $29.98M 100%
Unlock